Form 4 Filing for Contineum Therapeutics, Inc.

This filing details a Form 4 submission for Contineum Therapeutics, Inc. (CTNM), reporting transactions by Chief Scientific Officer, Lorrain Daniel S. On April 6, 2026, Daniel S. sold 4,170 shares of Class A Common Stock at a weighted average price of $13.4326 per share, with individual sales ranging from $13.08 to $13.60. These sales were executed under a 10b5-1 trading plan. Following the transaction, Daniel S. directly owns 147,712 shares. Additionally, 6,842 shares are held indirectly by a spouse. The filing was signed by Peter Slover as Attorney-in-Fact.